You just read:

Nektar Therapeutics Announces Publication of Two Manuscripts on Lead Immuno-oncology Candidate, Bempegaldesleukin (Bempeg) in Nature Communications

News provided by

Nektar Therapeutics

Feb 03, 2020, 08:00 ET